SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles

HK Stock Market Move | BRETON(01333) rose more than 11% in early trading. The company's unmanned driving special mining truck will have its global premiere on Friday this week.
.png)
HK Stock Market Move | JACOBSON PHARMA (02633) drops nearly 7%, mid-year earnings decrease by 5.36% year-on-year, dividend payout increases by 20% year-on-year.

CICC International: Upgrades YUM CHINA (09987) Target Price to 453.2 Hong Kong Dollars, Maintains "Outperform" Rating.
HK Stock Market Move | BRETON(01333) rose more than 11% in early trading. The company's unmanned driving special mining truck will have its global premiere on Friday this week.

HK Stock Market Move | JACOBSON PHARMA (02633) drops nearly 7%, mid-year earnings decrease by 5.36% year-on-year, dividend payout increases by 20% year-on-year.
.png)
CICC International: Upgrades YUM CHINA (09987) Target Price to 453.2 Hong Kong Dollars, Maintains "Outperform" Rating.

RECOMMEND

Tech Stocks, Crypto, and Gold Slump; U.S. Equities Break Key Support Amid Broad-based Sell-off
18/11/2025

Goldman Sachs’ Ten-year Investment Outlook: Artificial Intelligence and Emerging Markets As Core Growth Engines
18/11/2025

Consensus On Multiple Outcomes, Easing Trade Tensions, China–Germany High-level Financial Dialogue Convened In Beijing
18/11/2025


